Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices

Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact.”

Chiropractic Treatment for Sciatica: What You Need to Know

Chiropractic Treatment for Sciatica

Living with sciatica can feel like an uphill battle. Every step and every movement might trigger that sharp, shooting pain. But you’re not alone, and there are gentle, non-invasive options available that many have found helpful. In this guide, we’ll explore how chiropractic treatment for sciatica might be the key to easing your discomfort and […]

Learn More About How An Attorney Can Help Prove Your Cancer Misdiagnosis

Cancer Misdiagnosis

Receiving a cancer diagnosis is a life-changing event that can leave you feeling overwhelmed and uncertain about the future. However, when that diagnosis is later revealed to be a misdiagnosis, the emotional and physical toll can be devastating. If you or a loved one has experienced a cancer misdiagnosis, it’s important to know that you […]

Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics

“I am honored to lead Nimbus at this pivotal time in the company’s evolution,” said Abbas Kazimi. “Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I’m particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

Dave Mehalick, CEO of COEPTIS stated, “Partnering with NUBURU marks a significant step in COEPTIS’ journey toward pioneering innovative technology solutions. By harnessing the power of NexGen’s AI-driven capabilities, we are poised to not only enhance our own operational efficiencies but also redefine how businesses engage with their clients in the rapidly evolving defense and security landscape. This collaboration underscores our commitment to fostering growth through advanced technological integrations.”

Vitestro Unveils Aletta ™ | World’s 1st Autonomous Robotic Phlebotomy Device

Vitestro Unveils Aletta™

Aletta is the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection. As the exclusive ARPD™, Aletta sets the global industry standard for automated venous blood draws—enhancing clinical precision, safety, efficiency, and patient experience.

Phantom Neuro Receives FDA Breakthrough Device & TAP Designations, Solidifying Position as a Neurotech Leader

“Receiving both of these certified designations from the FDA is a tremendous validation of our work,” said Dr. Connor Glass, Founder and CEO of Phantom Neuro. “These recognitions validate our technology and reflect our commitment to creating scalable, real-world solutions that restore functionality and independence to amputees and those with functional disabilities. Our goal is to bring Phantom X to patients faster, and achievements like this accelerate our clinical and regulatory processes.”